ACR 0 3 0 3 B-clinical_variable
in 4 6 4 6 O
the 7 10 7 10 O
previous 11 19 11 19 B-upper_bound
6 20 21 20 21 I-upper_bound
months 22 28 22 28 I-upper_bound

Age 0 3 29 32 B-age
< 4 5 33 34 O
18 5 7 34 36 B-upper_bound
years 8 13 37 42 I-upper_bound

EBV 0 3 43 46 B-chronic_disease
IgG 4 7 47 50 I-chronic_disease
negative 8 16 51 59 O

Everolimus 0 10 60 70 B-treatment

Maintenance 0 11 71 82 O
immunosuppression 12 29 83 100 B-treatment
of 30 32 101 103 I-treatment
CNI 33 36 104 107 I-treatment
( 37 38 108 109 O
cyclosporine 38 50 109 121 B-treatment
or 51 53 122 124 O
tacrolimus 54 64 125 135 B-treatment
) 64 65 135 136 O

Male 0 4 137 141 B-gender

Proteinuria 0 11 142 153 B-clinical_variable
≥1 12 14 154 156 O
gram 15 19 157 161 I-lower_bound
/ 19 20 161 162 I-lower_bound
day 20 23 162 165 I-lower_bound
in 24 26 166 168 O
spot 27 31 169 173 O
urine 32 37 174 179 O
protein 38 45 180 187 O
/ 45 46 187 188 O
creatinine 46 56 188 198 O
ratio 57 62 199 204 O

Sirolimus 0 9 205 214 B-treatment

active 0 6 215 221 O
acute 7 12 222 227 O
antibody 13 21 228 236 B-chronic_disease
- 21 22 236 237 I-chronic_disease
mediated 22 30 237 245 I-chronic_disease
rejection 31 40 246 255 I-chronic_disease

active 0 6 256 262 O
acute 7 12 263 268 B-chronic_disease
cellular 13 21 269 277 I-chronic_disease
rejection 22 31 278 287 I-chronic_disease
( 32 33 288 289 O
ACR 33 36 289 292 B-chronic_disease
; 36 37 292 293 O
higher 38 44 294 300 O
than 45 49 301 305 O
borderline 50 60 306 316 O
) 60 61 316 317 O

antiproliferative 0 17 318 335 B-treatment
agent 18 23 336 341 I-treatment
( 24 25 342 343 O
azathioprine 25 37 343 355 B-treatment
, 37 38 355 356 O
MMF 39 42 357 360 B-treatment
or 43 45 361 363 O
MPA 46 49 364 367 B-treatment
) 49 50 367 368 O
with 51 55 369 373 O
either 56 62 374 380 O
steroids 63 71 381 389 B-treatment
or 72 74 390 392 O
not 75 78 393 396 O

eGFR 0 4 397 401 B-clinical_variable
≥30 5 8 402 405 O
ml 9 11 406 408 I-lower_bound
/ 11 12 408 409 I-lower_bound
min 12 15 409 412 I-lower_bound

eGFR<30 0 7 413 420 B-clinical_variable
ml 8 10 421 423 I-upper_bound
/ 10 11 423 424 I-upper_bound
min 11 14 424 427 I-upper_bound

female 0 6 428 434 B-gender
adult 7 12 435 440 O

kidney 0 6 441 447 B-treatment
transplant 7 17 448 458 I-treatment
recipients 18 28 459 469 O
older 29 34 470 475 O
than 35 39 476 480 O
18 40 42 481 483 B-lower_bound
years 43 48 484 489 I-lower_bound
old 49 52 490 493 O

patient 0 7 494 501 O
on 8 10 502 504 O
mTOR 11 15 505 509 B-treatment
inhibitor 16 25 510 519 I-treatment

patient 0 7 520 527 O
only 8 12 528 532 O
on 13 15 533 535 O
CNI 16 19 536 539 B-chronic_disease
( 20 21 540 541 O
cyclosporine 21 33 541 553 B-treatment
or 34 36 554 556 O
tacrolimus 37 47 557 567 B-treatment
) 47 48 567 568 O
and 49 52 569 572 O
steroids 53 61 573 581 B-treatment

recurrent 0 9 582 591 O
FSGS 10 14 592 596 B-chronic_disease

≥6 0 2 597 599 O
months 3 9 600 606 I-lower_bound
after 10 15 607 612 I-lower_bound
transplantation 16 31 613 628 B-treatment

